Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
Seidman
Ernest G
EG
Furst
Daniel E
DE
D018501:Antirheumatic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001379:Azathioprine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods*; D005838:Genotype; D006801:Humans; D008780:Methyltransferases / Q000235:genetics / Q000378:metabolism; D010597:Pharmacogenetics; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics
D018501:Antirheumatic Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine